AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Navigating the MRD Controversy in CLL
Exploring the challenges and potential benefits of minimal residual disease (MRD) detection in chronic lymphocytic leukemia (CLL), including discussions on MRD-guided trials, time-limited therapy, targeted agent doublets, and the debate between triplet and doublet therapies.